Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Cited In for PubMed (Select 20716250)

1.

Trajectories of Childbearing among HIV Infected Indian Women: A Sequence Analysis Approach.

Darak S, Mills M, Kulkarni V, Kulkarni S, Hutter I, Janssen F.

PLoS One. 2015 Apr 23;10(4):e0124537. doi: 10.1371/journal.pone.0124537. eCollection 2015.

2.

HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction.

Papp E, Mohammadi H, Loutfy MR, Yudin MH, Murphy KE, Walmsley SL, Shah R, MacGillivray J, Silverman M, Serghides L.

J Infect Dis. 2015 Jan 1;211(1):10-8. doi: 10.1093/infdis/jiu393. Epub 2014 Jul 16.

3.

Postnatal cytomegalovirus exposure in infants of antiretroviral-treated and untreated HIV-infected mothers.

Meyer SA, Westreich DJ, Patel E, Ehlinger EP, Kalilani L, Lovingood RV, Denny TN, Swamy GK, Permar SR.

Infect Dis Obstet Gynecol. 2014;2014:989721. doi: 10.1155/2014/989721. Epub 2014 Mar 3.

4.

Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study.

Kreitchmann R, Li SX, Melo VH, Fernandes Coelho D, Watts DH, Joao E, Coutinho CM, Alarcon JO, Siberry GK.

BJOG. 2014 Nov;121(12):1501-8. doi: 10.1111/1471-0528.12680. Epub 2014 Mar 7.

PMID:
24602102
5.

Prenatal ultrasound screening for fetal anomalies and outcomes in high-risk pregnancies due to maternal HIV infection: a retrospective study.

Reitter A, Stücker AU, Buxmann H, Herrmann E, Haberl AE, Schlößer R, Louwen F.

Infect Dis Obstet Gynecol. 2013;2013:208482. doi: 10.1155/2013/208482. Epub 2013 Sep 26.

6.

Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.

Sirois PA, Huo Y, Williams PL, Malee K, Garvie PA, Kammerer B, Rich K, Van Dyke RB, Nozyce ML; Pediatric HIVAIDS Cohort Study.

Pediatr Infect Dis J. 2013 Jun;32(6):648-55. doi: 10.1097/INF.0b013e318284129a.

7.

Combination antiretroviral use and preterm birth.

Watts DH, Williams PL, Kacanek D, Griner R, Rich K, Hazra R, Mofenson LM, Mendez HA; Pediatric HIV/AIDS Cohort Study.

J Infect Dis. 2013 Feb 15;207(4):612-21. doi: 10.1093/infdis/jis728. Epub 2012 Nov 29.

8.

Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, Powis K, Dryden-Peterson S, Creek T, Jimbo W, Madidimalo T, Makhema J, Essex M, Shapiro RL.

J Infect Dis. 2012 Dec 1;206(11):1695-705. doi: 10.1093/infdis/jis553. Epub 2012 Oct 12.

9.

Thirty years later: pregnancies in females perinatally infected with human immunodeficiency virus-1.

Badell ML, Lindsay M.

AIDS Res Treat. 2012;2012:418630. doi: 10.1155/2012/418630. Epub 2012 Aug 28.

10.

Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care.

Huntington SE, Thorne C, Bansi LK, Anderson J, Newell ML, Taylor GP, Pillay D, Hill T, Tookey PA, Sabin CA; UK Collaborative HIV Cohort (UK CHIC) Study and the National Study of HIV in Pregnancy and Childhood (NSHPC).

AIDS. 2013 Jan 2;27(1):95-103. doi: 10.1097/QAD.0b013e3283565df1.

11.

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.

Gibb DM, Kizito H, Russell EC, Chidziva E, Zalwango E, Nalumenya R, Spyer M, Tumukunde D, Nathoo K, Munderi P, Kyomugisha H, Hakim J, Grosskurth H, Gilks CF, Walker AS, Musoke P; DART trial team.

PLoS Med. 2012;9(5):e1001217. doi: 10.1371/journal.pmed.1001217. Epub 2012 May 15.

12.

Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa.

Ndirangu J, Newell ML, Bland RM, Thorne C.

Hum Reprod. 2012 Jun;27(6):1846-56. doi: 10.1093/humrep/des090. Epub 2012 Mar 21.

13.

Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment.

Hussain A, Moodley D, Naidoo S, Esterhuizen TM.

PLoS One. 2011;6(12):e27907. doi: 10.1371/journal.pone.0027907. Epub 2011 Dec 5.

14.

Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy.

Powis KM, Kitch D, Ogwu A, Hughes MD, Lockman S, Leidner J, van Widenfelt E, Moffat C, Moyo S, Makhema J, Essex M, Shapiro RL.

J Infect Dis. 2011 Aug 15;204(4):506-14. doi: 10.1093/infdis/jir307.

15.

Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception.

Huntington SE, Bansi LK, Thorne C, Anderson J, Newell ML, Taylor GP, Pillay D, Hill T, Tookey PA, Sabin CA; UK Collaborative HIV Cohort (UK CHIC) Study and the National Study of HIV in Pregnancy and Childhood (NSHPC).

AIDS. 2011 Aug 24;25(13):1647-55. doi: 10.1097/QAD.0b013e32834982af.

16.

Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.

Tariq S, Townsend CL, Cortina-Borja M, Duong T, Elford J, Thorne C, Tookey PA; European Collaborative Study; National Study of HIV in Pregnancy Childhood.

J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):326-33. doi: 10.1097/QAI.0b013e31821d34d0. Erratum in: J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):e117.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk